✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (242 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
41.28
4,31,412
68.55
1,70,343
58.97
1,26,191
22.52
1,22,511
18.45
1,06,523
22.01
95,164
19.27
94,827
52.25
91,486
20.64
70,655
28.57
67,442
41.17
62,121
55.32
55,860
80.49
55,049
110
53,499
44.63
42,630
81.18
36,634
43.57
36,239
33.21
32,340
36.85
29,122
38.47
27,636
33.27
26,383
-
24,611
-
24,289
114
22,852
27.20
22,833
51.67
21,475
87.35
20,977
84.31
20,896
53.85
19,493
466
18,639
64.38
18,441
27.91
17,704
36.53
17,448
10.87
16,719
143
16,412
46.29
14,995
24.82
14,613
63.77
14,282
26.99
13,841
28.59
12,745
20.50
10,871
48.87
10,650
78.36
10,529
24.40
10,082
28.06
9,888
31.29
9,599
49.13
9,584
24.74
8,701
20.81
8,267
58.97
8,179
29.88
6,735
21.09
6,685
48.48
6,654
26.34
6,316
32.91
6,003
130
5,468
-
4,955
90.08
4,350
82.45
4,308
32.63
4,061
-
3,942
18.80
3,744
27.21
3,711
16.93
3,648
41.88
3,648
61.23
3,485
23.53
3,468
35.98
3,183
34.55
2,914
274
2,771
8.13
2,634
22.60
2,618
394
2,527
-
2,406
23.99
2,366
-
2,165
34.27
1,943
41.49
1,760
142
1,701
24.46
1,647
14.89
1,632
23.57
1,562
23.61
1,463
23.06
1,454
55.65
1,447
31.92
1,399
26.31
1,347
64.60
1,295
14.48
1,018
12.53
1,002
-
975
19.49
956
46.34
915
44.61
870
20.19
868
40.84
838
40.25
833
24.59
813
7.18
804
-
802
20.53
795
3.29
785
39.73
699
41.15
657
21.86
603
29.33
599
28.27
555
49.30
528
38.04
508
15.11
499
-
455
-
436
38.18
433
22.47
420
39.51
415
-
413
60.71
401
46.29
372
41.92
368
71.71
364
30.99
364
52.89
348
19.76
336
148
306
96.68
297
25.54
295
71.56
294
30.13
289
28.25
277
32.76
244
36.24
241
66.38
238
9.77
237
51.30
232
-
227
22.30
217
22.48
216
-
187
9.75
182
14.59
179
10.04
174
660
171
-
168
150
159
29.47
158
34.59
157
19.23
154
40.94
151
31.42
147
32.48
147
10.73
146
-
140
12.32
136
13.36
128
12.82
124
17.61
120
16.50
118
-
114
29.66
111
33.86
105
179
103
16.66
102
20.59
101
14.42
98
12.86
92
19.16
92
11.75
90
20.59
89
-
86
28.86
86
7.83
84
36.24
84
51.20
80
382
77
-
72
59.12
71
-
68
16.38
67
13.36
66
33.97
66
14.80
62
8.45
61
94.04
60
20.51
59
15.33
57
3.63
55
-
51
-
50
60.42
47
100
43
95.31
42
-
40
11.93
40
11.16
40
-
39
16.67
39
-
39
-
39
24.59
38
27.09
38
82.16
38
9.03
37
18.99
37
13.91
35
-
33
8.20
33
8.51
29
34.04
29
39.24
29
161
29
125
28
-
27
12.37
26
64.38
22
22.78
22
32.04
21
71.70
21
-
20
-
17
16.33
17
-
15
64.63
15
-
15
-
14
-
12
10.88
11
48.77
11
-
10
21.76
10
-
10
-
10
87.37
7
709
6
-
6
291
6
-
5
79.18
5
-
5
-
5
33.77
4
-
3
-
2
Showing 5 242 of 242 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material